Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 231.38M P/E - EPS this Y -4.20% Ern Qtrly Grth -
Income -54.23M Forward P/E -11.08 EPS next Y 68.90% 50D Avg Chg 7.00%
Sales 14.8M PEG - EPS past 5Y - 200D Avg Chg 15.00%
Dividend N/A Price/Book 1.51 EPS next 5Y - 52W High Chg -28.00%
Recommedations 1.30 Quick Ratio 8.72 Shares Outstanding 98.90M 52W Low Chg 65.00%
Insider Own 41.87% ROA -18.18% Shares Float 39.64M Beta 1.01
Inst Own 30.25% ROE -32.91% Shares Shorted/Prior 509.36K/582.97K Price 2.77
Gross Margin -268.94% Profit Margin - Avg. Volume 1,024,758 Target Price 10.62
Oper. Margin -23.92% Earnings Date Aug 2 Volume 90,050 Change -5.14%
About AC Immune SA

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It is developing Crenezumab, a humanized, conformation-specific monoclonal antibody used to slow Alzheimer's disease (AD) progression; and Semorinemab, an investigational monoclonal anti-Tau antibody that targets the N-terminal portion of the Tau protein and is designed to bind to Tau and slow its spread between neurons for the treatment of AD. The company is also developing ACI-24.060 for the treatment of down syndrome-related AD; ACI-7104.056, to treat Parkinson's disease; and ACI-35.030, designs to stimulate a patient's immune system to produce antibodies against pathological phosphorylated Tau. In addition, it is developing diagnostic programs, consisting of PI-2620, a Tau diagnostic for AD, as well as non-AD Tauopathies; and ACI-12589, a-sync PET tracer that supports the differential diagnosis of multiple system atrophy from other neurodegenerative disease. Further, the company is researching and developing Morphomer Tau aggregation inhibitors to evaluate candidates in AD and NeuroOrphan Tauopathies. Additionally, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. The company has license agreements and collaborations with Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; and Eli Lilly and Company. AC Immune SA was incorporated in 2003 and is headquartered in Lausanne, Switzerland.

AC Immune SA News
04/11/24 We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
03/15/24 Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
03/14/24 AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
02/22/24 AC Immune Announces Upcoming Presentations at AD/PD™ 2024
02/21/24 AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
01/30/24 Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
01/22/24 AC Immune to Regain Global Rights to Crenezumab and Semorinemab
01/18/24 AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
01/08/24 5 Small-Cap Stocks to Play the January Effect
01/03/24 AC Immune (ACIU) Upgraded to Buy: Here's Why
01/03/24 AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
12/15/23 AC Immune Announces Pricing of Underwritten Offering of Common Shares
12/15/23 AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
12/13/23 AC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held by individual investors
12/12/23 The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
12/11/23 Alzheimer's Disease Space Evolves in 2023: Stocks in Focus
12/05/23 Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now?
12/01/23 AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
11/28/23 Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
11/27/23 Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
ACIU Chatroom

User Image Clutchiffi Posted - 2 days ago

$ACIU big one at close!

User Image LMDXWILLBOOM Posted - 3 days ago

Most Roche acquired companies still trade. Look at $aciu

User Image ElijahJobs Posted - 3 days ago

$ACIU Any major data expected for AD or PD this year? THX

User Image cantare Posted - 04/30/24

$ACIU is earnings this morning.

User Image PKinUK16 Posted - 04/29/24

$ACIU loaded up some June calls and common at $2.40 - topline readout by mid June. Binary event

User Image RodRosenstein Posted - 04/28/24

$ACIU

User Image cantare Posted - 04/24/24

$ACIU is this company dead

User Image RodRosenstein Posted - 1 month ago

$ACIU oops

User Image LMDXWILLBOOM Posted - 1 month ago

$LMDX we should ask $rhhby their opinion...this looks like a forward moving partnership. Assets still have to be sold so yes it could easily be a partnership like $aciu was.

User Image RodRosenstein Posted - 03/27/24

$ACIU

User Image GSMITH10107 Posted - 03/27/24

$ACIU if there was one under the radar biotech to be bought out, $ACIU would be my best guess. nobody talking about them, cash into 2026, Eli Lilly $LLY , janssen $JNJ , and genentech partnerships.. a bunch of big pharma understanding what they're doing + solid management + cash + big biotech funds buying = like a good recipe to me. ill take my risk here because dilution isn't on the horizon due to milestone payments being owed

User Image newdmontheblock Posted - 03/26/24

$ACIU Bidding the trend here. Unusual volume today, hit bottom of descending triangle and could test breakout in a month or so. Going light to test my TA skills.

User Image RodRosenstein Posted - 03/26/24

$ACIU Rod is dipping his toes in here.

User Image GSMITH10107 Posted - 03/26/24

$ACIU i added more. big named institutions just bought a huge offering at $3.50 I had my eyes on $ANVS for alzheimers but refocused my attention long term to $ACIU after deep research. I do believe one of them will be a massive success

User Image zztopps Posted - 03/26/24

$ACIU We'll this is disconcerting. Long term hold just got longer. GLLs.

User Image moonbear Posted - 03/22/24

$ACIU Started a new position. I like their partnerships with Roche and Lilly

User Image epsguid Posted - 03/14/24

$ACIU reported a loss of $0.06, consensus was ($0.07) via @eWhispers #epsbeat http://eps.sh/d/aciu

User Image Stock_Titan Posted - 03/14/24

$ACIU AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update https://www.stocktitan.net/news/ACIU/ac-immune-reports-full-year-2023-financial-results-and-provides-a-llurhxwg9w79.html

User Image Gurujoe Posted - 03/11/24

$ACIU presentation from AD/PD 2024, end (page 115), finishing randomization part 1 schedules for March 2024. Looks like preamble but not data drop. Still long.. https://ir.acimmune.com/static-files/ffbd379b-df5e-448a-8c88-0aaaf8b6bfe9

User Image cantare Posted - 03/08/24

$ACIU any word from the conference?

User Image cantare Posted - 03/07/24

$ACIU very low volume last few days

User Image FREEAMERICA Posted - 03/07/24

$ACIU total comment blackout from the conference - their big data is saturdays seasion .. WAITING

User Image Gurujoe Posted - 2 months ago

$ACIU, good luck, longs; tomorrow is a significant data drop (catalyst), and the presentation is in the GMT zone, so we should have some updates pre-market. AC Immune is one of the most active presenters at the AD/PD 2024 conference, with 11 presentations and active participation in 25 conference programs.

User Image insiderfinancial Posted - 2 months ago

Tonight's video is now posted. Some stocks we cover: $CRWD earnings preview Tuesday after close $ACIU $VAXX presenting tomorrow at International Conference on Alzheimer's and Parkinson's $PAY good earnings and guidance tonight $RNLX takeover play Have a great Tuesday, everyone! https://youtu.be/Csr-kxdp7_E?si=wSz8FgL1wynJetwU

User Image TickerDD_com Posted - 2 months ago

From 3/1/2024, looking back across 22 Month-Ends for ACIU, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $ACIU #ACIU #ACIUStock #TickerDD #ACIUPrice https://www.youtube.com/watch?v=78VQrXZKT9I

User Image Awesom69Trade Posted - 2 months ago

$ACIU $3.69 Premarket! It’s a clues to me for a big pop coming, imo

User Image cantare Posted - 2 months ago

$ACIU healthy pull back after climbing for consecutive days.

User Image LMDXWILLBOOM Posted - 02/29/24

$LMDX the $aciu partnership with Roche isn't the only one ending! Job cuts, postponing this Lumiradx deal to mid '24, poor '23 performance leads me to believe Roche is going all in on Lumiradx! Could be massive!

User Image LMDXWILLBOOM Posted - 02/29/24

$LMDX Hey $aciu are there similarities between you and Lumiradx in the way Roche is dealing with us?

User Image mikebiotechstonks Posted - 02/27/24

$ACIU 2.80 to 3.90, still holding!

Analyst Ratings
HC Wainwright & Co. Buy Mar 15, 24
HC Wainwright & Co. Buy Nov 13, 23
HC Wainwright & Co. Buy Aug 7, 23
HC Wainwright & Co. Buy Jun 28, 23
HC Wainwright & Co. Buy May 1, 23
HC Wainwright & Co. Buy Apr 19, 23
HC Wainwright & Co. Buy Mar 17, 23
SVB Leerink Outperform Jul 11, 22
SVB Leerink Outperform Dec 20, 21